Spark Biomedical
Dallas, US · Founded 2023 · Delaware corporation · 2 known investors
Spark Biomedical develops wearable neurostimulation devices for bioelectronic medicine applications, primarily targeting mental health, women's health, hemostasis, and pediatrics. The company's FDA-cleared product treats opioid withdrawal and is conducting multiple clinical trials to expand into additional therapeutic areas.
Founders & leadership
DP

Daniel PowellinPresident & Chief Executive Officer
AC

Alejandro Covalin, PhDinChief Technology Officer
NK

Navid Khodaparast, PhDinChief Science Officer
AC
Alejandro CovalinChief Technology Officer and Director
NK
Navid KhodaparastChief Science Officer and Director
TC
Ted CostopoulosDirector
CR
Carl R. DeeleyDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$16.2MraisedMay 2023 · 127 investors · Other Health CareRule 506(b)
▶$16.2MraisedMay 2023 · 127 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alejandro CovalinExecutive Officer, Director
- Navid KhodaparastExecutive Officer, Director
- Ted CostopoulosDirector
- Carl R. DeeleyDirector
- Daniel PowellExecutive Officer, Director
- Offering amount
- $21.8M
- Amount sold
- $16.2M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Spark Biomedical Awarded Funding from Wellcome Leap for Women’s Health Innovationfinance.yahoo.com · 2025
- Spark Biomedical Secures $15M Series A To Advance Drug-Free Wearable Neurostimulation Therapiesglobenewswire.com · 2025
- Dallas' Spark Biomedical Raises $15M Series A to Advance Its Wearable Neurostimulation Therapies » Dallas Innovatesdallasinnovates.com · 2025
- Spark Biomedical Raises $15M in Series A Fundingfinsmes.com · 2025